COCP Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CCS Q1 2026 Earnings EPS Surges Past Expectations Delivering 68 Beat HBIO Q1 2026 Earnings Loss Narrower Than Expected on Cost Controls Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status SLVM Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds GIII Q1 2026 Earnings EPS Falls Short Amid Challenging Retail Environment